Articles From: Gazit-Globe to Report First Quarter 2014 Financial Results on May 28, 2014 to GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma


TEL AVIV, Israel, May 20, 2014 (GLOBE NEWSWIRE) -- Gazit-Globe (NYSE:TSX) (TASE:GZT), one of the world's leading multi-national real estate companies focused on acquisition, development and redevelopment of supermarket-anchored shopping centers in major urban markets, announced today that it will release its first quarter 2014 financial results on Wednesday, May 28, 2014.
Sign-up for Gazit-Globe to Report First Quarter 2014 Financial Results on May 28, 2014 investment picks
REDWOOD CITY, Calif., May 20, 2014 (GLOBE NEWSWIRE) -- Relypsa, Inc. (Nasdaq:RLYP) , a biopharmaceutical company, today announced that it has entered into a multi-year commercial manufacturing and supply agreement with DSM Fine Chemicals Austria NFG GMBH & Co.
Sign-up for Relypsa Announces Commercial Manufacturing Agreement With DSM Fine Chemicals investment picks
NASHUA, N.H., May 20, 2014 (GLOBE NEWSWIRE) -- SMTP, Inc. (Nasdaq:SMTP) , a global provider of email delivery services, announced today that it will be a featured presenter at the 3rd Annual Marcum MicroCap Conference on Thursday, May 29, 2014 in New York City at the Grand Hyatt Hotel.
Sign-up for SMTP, Inc. to Present at the Third Annual Marcum MicroCap Conference investment picks
MIDLAND, Mich., May 20, 2014 (GLOBE NEWSWIRE) -- Chemical Financial Corporation (Nasdaq:CHFC) today announced that the Board of Directors of the Corporation declared a second quarter 2014 cash dividend on its common stock of $0.23 per share.
Sign-up for Chemical Financial Corporation Announces Second Quarter Cash Dividend investment picks
NATICK, Mass., May 20, 2014 (GLOBE NEWSWIRE) -- Karyopharm Therapeutics Inc. (Nasdaq:KPTI) , a clinical-stage pharmaceutical company focused on the discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases, today announced that its lead drug candidate, Selinexor (KPT-330), has received orphan drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of Diffuse Large B-Cell Lymphoma (DLBCL). The designation is designed to encourage the development of drugs which may provide significant benefit to patients suffering from rare diseases.
Sign-up for Karyopharm Announces Second Orphan Drug Designation for Selinexor in Diffuse Large B-Cell Lymphoma (DLBCL) investment picks
YAVNE, Israel, May 20, 2014 (GLOBE NEWSWIRE) -- MediWound Ltd.
Sign-up for MediWound Announces Successful GMP Manufacturing Audit by the Israeli Ministry of Health investment picks
FOUNTAIN VALLEY, Calif., May 20, 2014 (GLOBE NEWSWIRE) -- MEDL Mobile, Inc. (OTCBB:MEDL) , a leading developer of mobile applications and the majority shareholder of Hang With, Inc. has announced that Hang w/ will now allow users to embed their own profile on any website or blog - allowing both live and archived content to be viewed from the web.
Sign-up for Hang w/ Releases Live Streaming Web Widget investment picks
SALT LAKE CITY, May 20, 2014 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) today presented new data from a clinical validation study of Prolaris at the 2014 American Urological Association (AUA) Annual Meeting in Orlando, Fla.
Sign-up for Prolaris(R) Test Predicts Mortality Risk in Prostate Cancer Biopsy Study investment picks
SAN DIEGO, May 20, 2014 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (Nasdaq:KTOS) , a leading National Security Solutions provider, announced today that its Kratos Defense and Rocket Support Services Division (KDRSS) recently received a $9 million contract award to support the prototype development of the railgun fire control system and hypervelocity guided projectile.
Sign-up for Kratos Receives $9 Million Contract Award for Railgun Fire Control and Hypervelocity Guided Projectile Prototype Development investment picks
SHANGHAI, China, May 20, 2014 (GLOBE NEWSWIRE) -- JA Solar Holdings Co., Ltd.
Sign-up for JA Solar to Hold Annual General Meeting on June 30, 2014 investment picks
HOUSTON, May 20, 2014 (GLOBE NEWSWIRE) -- Memorial Production Partners LP (Nasdaq:MEMP) announced today that William J.
Sign-up for Memorial Production Partners LP to Present at NAPTP Investor Conference investment picks
NEW YORK, May 20, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) , the world's leading provider of market technology, today announced the launch of a new business intelligence solution for capital market operators around the globe, MiQ.
Sign-up for NASDAQ OMX Launches MiQ, a New Business Intelligence Product for Global Capital Market Operators investment picks
HAIFA, Israel, May 20, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc .
Sign-up for Pluristem Receives Clearance From South Korea to Use PLX Cells Manufactured at Its New Facility in Its Advances Studies investment picks
BEIJING, May 20, 2014 (GLOBE NEWSWIRE) -- iKang Healthcare Group, Inc. ("iKang" or the "Company") (Nasdaq:KANG) , the largest provider in China's fast growing private preventive healthcare services market in terms of revenue in 2013, announced today it will attend the 2014 UBS Global Healthcare Conference to be held on May 19 th to 21 st at Sheraton New York Hotel in New York, United States.
Sign-up for iKang to Attend 2014 UBS Global Healthcare Conference in New York investment picks
NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- The NASDAQ OMX Group, Inc. (Nasdaq:NDAQ) today announced that it priced a public offering of $500 million aggregate principal amount of 4.25% senior notes due 2024.
Sign-up for NASDAQ OMX Prices $500 Million Senior Notes Offering investment picks
NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the District of Colorado on behalf of all purchasers of the securities of Advanced Emissions Solutions, Inc., ("Advanced Emissions Solutions" or the "Company") (Nasdaq:ADES) within the class period of March 14, 2013 through March 12, 2014.
Sign-up for Wolf Haldenstein Adler Freeman & Herz LLP Announces the Filing of a Securities Class Action Against Advanced Emissions Solutions, Inc. -- ADES investment picks
NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP announces that a class action lawsuit has been filed in the United States District Court for the Southern District of Texas on behalf of all purchasers of the securities of KBR Inc., ("KBR" or the "Company") (NYSE:KBR) within the class period of April 25, 2013 through May 5, 2014.
Sign-up for Wolf Haldenstein Adler Freeman & Herz LLP Announces the Filing of a Securities Class Action Against KBR Inc. -- KBR investment picks
NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- Pomerantz LLP has filed a class action lawsuit against Advanced Emissions Solutions, Inc. ("Advanced Emissions" or the "Company") (Nasdaq:ADES) and certain of its officers.
Sign-up for SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Advanced Emissions Solutions, Inc. of Class Action Lawsuit and Upcoming Deadline -- ADES investment picks
EL PASO, Texas, May 19, 2014 (GLOBE NEWSWIRE) -- Western Refining, Inc. (NYSE:WNR) announced today that Company management will participate in the UBS Global Oil and Gas Conference, in Austin, Texas, on Tuesday, May 20, 2014.
Sign-up for Western Refining to Participate in the UBS Global Oil and Gas Conference investment picks
NEW YORK, May 19, 2014 (GLOBE NEWSWIRE) -- INTL FCStone Inc. (Nasdaq:INTL) ("the Company") today announced that the U.S. Court of Appeals for the Seventh Circuit has denied the petition by the Liquidation Trustee of the Sentinel Liquidation Trust for a rehearing and a rehearing en banc of that court's March 2014 decision in favor of the Company's subsidiary, FCStone, LLC, in the matter concerning the 2007 bankruptcy of Sentinel Management Group, Inc. The only recourse now open to the Liquidation Trustee is an appeal to the U.S. Supreme Court, for which the Liquidation Trustee has 90 days from today to lodge a petition.
Sign-up for Sentinel Trustee's Petition for Rehearing is Denied investment picks
SUNNYVALE, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY) , announced today that its management is scheduled to present at the 2014 Jefferies Global Healthcare Conference in New York City on Tuesday, June 3, 2014 at 3 p.m. ET/ 12 p.m. PT.
Sign-up for Accuray Incorporated to Present at 2014 Jefferies Global Healthcare Conference investment picks
MIAMI, May 19, 2014 (GLOBE NEWSWIRE) -- Spanish Broadcasting System, Inc. (the "Company" or "SBS") (Nasdaq:SBSA) is pleased to announce that, on May 16, 2014, the Company received approval from The Nasdaq Stock Market ("NASDAQ") to transfer the listing of the Company's common stock from The NASDAQ Capital Market to The NASDAQ Global Market.
Sign-up for Spanish Broadcasting System, Inc. Announces Transfer of Listing to The NASDAQ Global Market investment picks
HOUSTON, May 19, 2014 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) announced today that it will webcast its presentation from the Goldman Sachs Lodging, Gaming, Restaurant and Leisure Conference at 9:45 a.m. (Eastern), Monday, June 2.
Sign-up for Sysco to Webcast Presentation From the 2014 Goldman Sachs Lodging, Gaming, Restaurant and Leisure Conference investment picks
BURLINGTON, Mass., May 19, 2014 (GLOBE NEWSWIRE) -- Exa ® Corporation (Nasdaq:EXA) , a global innovator of fluid simulation solutions for product engineering, today announced that it will release its financial results for the first quarter of fiscal 2015, ended April 30, 2014, after market close on Thursday, May 29, 2014.
Sign-up for Exa Corporation Announces Date of First Quarter Fiscal 2015 Financial Results Conference Call and Webcast investment picks
ROCK HILL, S.C., May 19, 2014 (GLOBE NEWSWIRE) -- 3D Systems (NYSE:DDD) announced today that its Board of Directors was re-elected at the Annual Meeting of Stockholders held today and that the Board also elected William D.
Sign-up for 3D Systems Holds Annual Meeting of Stockholders and Elects William Humes to Board of Directors investment picks
DURHAM, N.C., May 19, 2014 (GLOBE NEWSWIRE) -- Chimerix, Inc. (Nasdaq:CMRX) , a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it is offering to sell 6,200,000 shares of its common stock in an underwritten public offering.
Sign-up for Chimerix Announces Commencement of Public Offering of Common Stock investment picks
CHICAGO, May 19, 2014 (GLOBE NEWSWIRE) -- Orbitz Worldwide, Inc. (NYSE:OWW) today announced an underwritten public offering of 7.5 million shares of its common stock by an affiliate of Travelport Limited (the "Selling Stockholder"). The underwriters have a 30-day option to purchase up to an additional 1.125 million shares from the Selling Stockholder.
Sign-up for Orbitz Worldwide Announces Secondary Common Stock Offering by Selling Stockholder investment picks
CARLSBAD, Calif., May 19, 2014 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC) , the parent company of Alphatec Spine, Inc., a medical device company that provides physician-inspired solutions for patients with spinal disorders, today announced it will present at Jefferies 2014 Global Healthcare Conference on Wednesday, June 4, 2014 at 4:30 PM Eastern Time at New York's Grand Hyatt Hotel.
Sign-up for Alphatec Spine to Present at Jefferies 2014 Global Healthcare Conference investment picks
PARSIPPANY, N.J., May 19, 2014 (GLOBE NEWSWIRE) -- Avis Budget Group, Inc. (Nasdaq:CAR) announced today that its wholly-owned subsidiary, Avis Budget Car Rental, LLC, has completed an offering of $400 million aggregate principal amount of 5.125% senior notes due 2022.
Sign-up for Avis Budget Group Announces Closing of $400 Million Senior Notes Offering investment picks
Company Announcement No statistically significant difference in progression free survival in ofatumumab plus chemotherapy treatment arm compared to rituximab plus chemotherapy Detailed data will be presented at an upcoming medical conference LONDON and COPENHAGEN, Denmark, May 19, 2014 (GLOBE NEWSWIRE) -- GlaxoSmithKline plc (LSE:GSK) and Genmab A/S (Copenhagen:GEN) announced today that the Phase III study (ORCHARRD) of ofatumumab (Arzerra(tm)) plus chemotherapy versus rituximab plus chemotherapy to treat relapsed or refractory diffuse large B-cell lymphoma (DLBCL) did not meet its primary endpoint as there was no statistically significant difference in progression free survival (PFS) between the treatment arms.
Sign-up for GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Gazit-Globe to Report First Quarter 2014 Financial Results on May 28, 2014 to GSK and Genmab Announce Topline Results from a Pivotal Head to Head Study of Ofatumumab in Combination With Chemotherapy vs Rituximab in Combination with Chemotherapy for the Treatment of Relapsed or Refractory Diffuse Large B-cell Lymphoma
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry